Analyzing the forecast for malignant neoplasms mortality among U.S. women from 2024 to 2028, we observe a consistent year-on-year decrease. Starting from 146.2 female deaths per hundred thousand in 2024, the rate gradually reduces to 136.2 by 2028. This pattern reflects a compounded annual growth rate (CAGR) of approximately -1.75%, indicating a steady decline in mortality rates.
Future trends to watch include the impact of advancements in early detection and treatment technologies, changes in healthcare policies, and lifestyle shifts which could further influence cancer mortality rates. Ongoing research and healthcare innovations are crucial to sustaining and potentially accelerating this downward trend.
